DM
GNCA

Deerfield Management’s Genocea Biosciences, Inc. GNCA Stock Holding History

Deerfield Management’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-59,875
Closed -$2.92M – 107
2017
Q1 		$2.92M Sell
59,875
-26,032
-30% -$1.02M 0.11% 94
2016
Q4 		$2.83M Hold
85,907
– – 0.12% 84
2016
Q3 		$3.52M Hold
85,907
– – 0.16% 68
2016
Q2 		$2.82M Sell
85,907
-12,500
-13% -$458K 0.11% 81
2016
Q1 		$6.09M Sell
98,407
-6,250
-6% -$199K 0.26% 67
2015
Q4 		$4.41M Buy
104,657
+42,000
+67% +$2M 0.18% 87
2015
Q3 		$3.43M Sell
62,657
-7,875
-11% -$781K 0.13% 101
2015
Q2 		$7.75M Sell
70,532
-35,000
-33% -$3.25M 0.26% 81
2015
Q1 		$10M Buy
105,532
+30,000
+40% +$2.12M 0.32% 63
2014
Q4 		$4.23M Buy
75,532
+6,250
+9% +$427K 0.15% 87
2014
Q3 		$5.02M Buy
69,282
+8,880
+15% +$972K 0.18% 90
2014
Q2 		$9.06M Sell
60,402
-22,096
-27% -$3.35M 0.36% 67
2014
Q1 		$12M Buy
+82,498
New +$10.1M 0.49% 55

Other funds holding GNCA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Deerfield Management's GNCA Position: Q2 2017 in Review

Deerfield Management sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2017, closing a stake of 59,875 shares — an estimated $2.92M sold.

Deerfield Management first reported a position in GNCA in Q1 2014 and held it in 13 quarters. The position peaked at $12M in Q1 2014. 61 funds tracked by Wall St. Rank hold GNCA as of Q2 2017.

  • Deerfield Management reported no remaining Genocea Biosciences, Inc. position as of Q2 2017 after selling out during the quarter.
  • Deerfield Management sold 59,875 Genocea Biosciences, Inc. shares in Q2 2017, an estimated $2.92M.
  • Deerfield Management first reported a position in Genocea Biosciences, Inc. in Q1 2014 and held it in 13 quarters.
  • Deerfield Management's Genocea Biosciences, Inc. position peaked at $12M in Q1 2014.
  • 61 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2017.

Based on Deerfield Management's 13F filing for Q2 2017, filed 14 Aug 2017.